Calixar

Calixar SAS, a startup based in Lyon, France, offers services focused on membrane proteins. Co-founded in January 2011 by Chairman and co-founder Emmanuel Dejean and Pierre Falson, Calixar provides comprehensive services centered on membrane proteins (which account for over 70% of therapeutic targets), including: identification, production, extraction, purification, stabilization, and crystallization. Its patented technology has been validated across a range of targets (including GPCR receptors, ion channels, transporters, and viral proteins), enabling the isolation and purification of any type of membrane protein in its fully native form, maintaining stability in solution.